期刊文献+

残胃癌nm23、p53、C-erbB-2癌基因产物的表达及意义

Expression of nm23, p53 and C-erbB-2 Protein in the Stump Gastric Carcinoma
原文传递
导出
摘要 目的 :探讨残胃癌中nm2 3、p53、C erbB 2癌基因产物的表达与临床病理特点的关系。方法 :应用免疫组织化学S P法检测52例残胃癌中nm2 3、p53、C erbB 2癌基因产物的表达。结果 :52例残胃癌中 ,nm2 3阳性率 65 4% ,p53阳性率 2 5 % ,C erbB 2阳性率40 4%。三者的阳性表达水平与肿瘤的病理组织学分级差异显著。结论 :nm、p53、C erbB 2在残胃癌中的表达与肿瘤组织学分级有关 ,三者均可作为判断肿瘤恶性度的客观指标。残胃癌中C erbB 2、p53过表达nm2 3低表达是其易于浸润和转移的原因之一。C erbB Purpose: To study the relationship between the expression of nm23,p53 and C-erbB-2 protein and the clinicopathologic properties in stump gastric carcinoma (SGC). Methods: The expression of nm23,p53 and C-erbB-2 protein in 52 cases of SGC were examined using S-P immunohistochemical method. Results: The positive cxpression of nm23,p53 and C-erbB-2 protein was 65.4%,25% and 40.4%,respectively. There was significant difference between those protain expression levels and tumor's histological grades. Conclusion: The expression of nm23,p53 and C-erbB-2 shows positive correlation with tumor's histological grades. They can be used as objective parameters for the determination of maligant degree in stump gastric carcinoma. The results suggest that C-erbB-2 and p53 protein overexpression and nm23 protein lowexpression may be one of the causes of SGC biological feature.Serial tests of C-erbB-2,nm23 and p53 protein can be used the markers to evaluate the patients prognosis.
作者 陈汉章
出处 《临床消化病杂志》 2003年第4期164-165,共2页 Chinese Journal of Clinical Gastroenterology
关键词 残胃肿瘤 NM23 P53 C-ERBB-2 免疫组织化学 Stump gastric carcinona nm23 p53 C-erbB-2 Immunohistochemistry
  • 相关文献

参考文献4

  • 1[1]Paupe M. Tumour associated E-cadherin mutations after cellular morphology, decrease cellulu adhesion and increase cellular motility. Oncogene,1999,18(30) :4301. 被引量:1
  • 2[2]Nakajima M, Sawada H, Yamada Y, et al. The prognostic significance of amplification and overexpression of CX-met and C-erbB-2 in human gastric carcinomas. Cancer, 1999,85(9): 1894. 被引量:1
  • 3[3]Souza RF, BargenJA, SouleEH, et al. p21 expression is aprognostic factor in patients with p53-negative gastric cancer. Cancer Lett,200,148(2): 181. 被引量:1
  • 4[4]Uchino S, Noguchi M, Ochiai A, et al. p53 mutation in gestric cancer: A genetic model for carcinogenesis is common to gastric and colorectal. lnt J Cancer, 1993,54: 759. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部